Tesamorelin reduces visceral fat in HIV lipodystrophy
study037
10.1056/NEJMoa0911289
New England Journal of Medicine
randomized clinical trial
Tesamorelin evaluated for visceral adipose reduction.
Significant decreases in visceral adipose tissue observed.
tesamorelin
fat-loss|hormone-optimization
gh-optimization-stack
tesamorelin-vs-sermorelin
published